Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Sprint Bioscience

Market Cap: SEK 60.1m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Magle Chemoswed Holding

Market Cap: SEK 379.9m

Engages in research and development of pharmaceutical and medical device products in Sweden.

AstraZeneca

Market Cap: SEK 171.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Swedish Orphan Biovitrum

Market Cap: SEK 97.1b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Saniona

Market Cap: SEK 1.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

Abera Bioscience

Market Cap: SEK 102.9m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Camurus

Market Cap: SEK 40.0b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Vitrolife

Market Cap: SEK 17.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Oncopeptides

Market Cap: SEK 1.2b

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Nanologica

Market Cap: SEK 103.4m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Orexo

Market Cap: SEK 1.0b

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

AcouSort

Market Cap: SEK 66.0m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Alvotech

Market Cap: SEK 2.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Devyser Diagnostics

Market Cap: SEK 2.3b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Xbrane Biopharma

Market Cap: SEK 646.5m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

NextCell Pharma

Market Cap: SEK 103.8m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

Bonesupport Holding

Market Cap: SEK 19.3b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BioGaia

Market Cap: SEK 10.8b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Egetis Therapeutics

Market Cap: SEK 1.9b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Swedencare

Market Cap: SEK 5.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Hansa Biopharma

Market Cap: SEK 3.3b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

BICO Group

Market Cap: SEK 1.4b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Biovica International

Market Cap: SEK 166.8m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Moberg Pharma

Market Cap: SEK 421.8m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.